Atypical depression: Current status

Current Opinion in Psychiatry

Volumn 17, Issue 1, 2004, Pages 37-41

  Quitkin, Frederic M ^a,b   Davies, Carrie A ^a  

^a New York State Psychiatric Institute ^*  (United States)

^b NONE   (United States)

Author keywords

Chromium picolinate; Chronic early onset atypical depression; Hypofunction hypothalamic pituitary adrenal axis

Indexed keywords

CHROMIUM PICOLINATE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; PHENELZINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ATYPICAL DEPRESSION; HEMISPHERIC DOMINANCE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOPHYSIS FUNCTION; MALADJUSTMENT; MELANCHOLIA; PANIC; REVIEW; VALIDATION PROCESS;

EID: 4143136577     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-200401000-00007     Document Type: Review

References (20)

1. Bruder GE, Stewart JW, McGrath PJ, et al. Atypical depression: enhanced right hemispheric dominance for perceiving emotional chimeric faces. J Abnorm Psychol 2002; 111:446-454. This paper describes a potential physiological basis for rejection sensitivity.
2. Stewart JW, McGrath PJ, Quitkin FM. Do age of onset and course of illness predict different treatment outcome among DSM-IV depressive disorders with atypical features? Neuropsychopharmacology 2002; 26:237-245. This paper describes a useful division of Columbia Depression into subtypes.
3. Stewart JW, Bruder GE, McGrath PJ, Quitkin FM. Do age of onset and course of illness define biologically distinct groups within atypical depression? J Abnorm Psychol 2003; 112:253-262. This paper provides important support for Stewart's thesis.
4. Gold PW, Gabry KE, Yasuda MR, Chrousos GP. Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications. Endocrinol Metab Clin North Am 2002; 31:37-62. This paper suggests the presence of hypofunction, not hyperfunction, of the HPA axis in atypical depression.
5. Agosti V, McGrath PJ. Comparison of the effects of fluoxetine, imipramine, and placebo on personality in atypical depression. J Affect Disord 2002; 71:113-120. This work demonstrates personality changes with mood improvement.
6. Davidson JR, Abraham K, Connor KM, McLeod MN. Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol Psychiatry 2003; 53:261-264. This work discusses chromium efficacy.
7. Angst J, Gamma A, Sellaro R, et al. Toward validation of atypical depression in the community: results of the Zurich cohort study. J Affect Disord 2002; 72:125-138. This is an important update of the prospective study.
8. Parker G, Roy K, Mitchell P, et al. Atypical depression: a reappraisal. Am J Psychiatry 2002; 159:1470-1479.
9. Kendler KS, Eaves LJ, Walters EE, et al. The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry 1996; 53:391-399.
10. Sullivan PF, Kessler RC, Kendler KS. Latent class analysis of lifetime depressive symptoms in the National Comorbidity Survey. Am J Psychiatry 1998; 155:1398-1406.
11. Quitkin FM, Stewart JW, McGrath PJ, et al. Columbia atypical depression: a subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo. Brit J Psychiatry Suppl 1993; 21:30-34.
12. Dillon WR, Goldstein M. Multivariable analysis: methods and applications. New York: Wiley; 1984.
13. Quitkin FM, McGrath PJ, Stewart JM, et al. Atypical depression, panic attacks, and response to imipramine and phenelzine: a replication. Arch Gen Psychiatry 1990; 47:935-941.
14. Liebowitz MR, Quitkin FM, Stewart JW, et al. Antidepressant specificity in atypical depression. Arch Gen Psychiatry 1988; 45:129-137.
15. Parsons B, Quitkin F, McGrath P, et al. Phenelzine, imipramine, and placebo in borderline patients meeting Columbia criteria for atypical depression. Psychopharmacol Bull 1989; 25:524-534.
16. Keller J, Bhargave T, Gergen JA, et al. Neuropsychological differentiation of depression and anxiety. J Abnorm Psychiatry 2000; 109:3-10.
17. Davidson J, Miller RD, Turbull CD, Sullivan JL. Atypical depression. Arch Gen Psychiatry 1982; 39:527-534.
18. Posterak MA, Zimmerman M. Partial validation of the atypical features subtype of major depressive disorder. Arch Gen Psychiatry 2002; 59:70-76. This paper validates many, though not all, aspects of atypical depression.
19. Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 2002; 7:254-275.
20. Levitan RD, Vaccarino FJ, Brown GM, Kennedy SH. Low-dose dexamethasone challenge in women with atypical major depression: pilot study. J Psychiatry Neurosci 2002; 27:47-51. This paper supports the possibility of hypofunction of the HPA axis in atypical depression.